These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 22392347)

  • 1. Toxicity of amphetamines: an update.
    Carvalho M; Carmo H; Costa VM; Capela JP; Pontes H; Remião F; Carvalho F; Bastos Mde L
    Arch Toxicol; 2012 Aug; 86(8):1167-231. PubMed ID: 22392347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria: key players in the neurotoxic effects of amphetamines.
    Barbosa DJ; Capela JP; Feio-Azevedo R; Teixeira-Gomes A; Bastos Mde L; Carvalho F
    Arch Toxicol; 2015 Oct; 89(10):1695-725. PubMed ID: 25743372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology.
    Kelly JP
    Drug Test Anal; 2011; 3(7-8):439-53. PubMed ID: 21755607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxicity of amphetamines during the adolescent period.
    Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP
    Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.
    Halpin LE; Collins SA; Yamamoto BK
    Life Sci; 2014 Feb; 97(1):37-44. PubMed ID: 23892199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004.
    De Letter EA; Piette MH; Lambert WE; Cordonnier JA
    Med Sci Law; 2006 Jan; 46(1):37-65. PubMed ID: 16454462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the mechanism of action of amphetamines.
    Fleckenstein AE; Volz TJ; Riddle EL; Gibb JW; Hanson GR
    Annu Rev Pharmacol Toxicol; 2007; 47():681-98. PubMed ID: 17209801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Khat and synthetic cathinones: a review.
    Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamines abuse and depression: Focus on TRPC channels.
    Fu YP; Wang Y
    Exp Neurol; 2023 Jun; 364():114391. PubMed ID: 36996966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
    Cadet JL; Krasnova IN; Jayanthi S; Lyles J
    Neurotox Res; 2007 Apr; 11(3-4):183-202. PubMed ID: 17449459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.
    Achat-Mendes C; Ali SF; Itzhak Y
    Neuropsychopharmacology; 2005 Jun; 30(6):1128-37. PubMed ID: 15688084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis.
    Dias da Silva D; Carmo H; Lynch A; Silva E
    Arch Toxicol; 2013 Dec; 87(12):2165-85. PubMed ID: 23820845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
    Steinkellner T; Freissmuth M; Sitte HH; Montgomery T
    Biol Chem; 2011 Jan; 392(1-2):103-15. PubMed ID: 21194370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer psychostimulants: pharmacology and differences.
    Iversen L; White M; Treble R
    Neuropharmacology; 2014 Dec; 87():59-65. PubMed ID: 24456744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential adverse effects of amphetamine treatment on brain and behavior: a review.
    Berman SM; Kuczenski R; McCracken JT; London ED
    Mol Psychiatry; 2009 Feb; 14(2):123-42. PubMed ID: 18698321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-induced movement disorder.
    Downes MA; Whyte IM
    Emerg Med Australas; 2005 Jun; 17(3):277-80. PubMed ID: 15953231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity.
    Wood DM; Dargan PI
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):227-33. PubMed ID: 22564711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amphetamine abuse and drug interactions].
    Horwitz H; Skanning P; Askaa B; Jürgens G
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.